References
- Riccardi V M, Sujanski E, Smith A C, Francke U. Chromosomal imbalance in the aniridia-Wilms' tumor association: 11p interstitial deletion. Pediatrics 1978; 61: 604–10
- Turleau C, de Grouchy J, Tournade M F, Gagnadoux M F, Junien C. Del 11p/aniridia complex: Report of three patients and review of 37 observations from the literature. Clin Genet 1984; 26: 256–62
- Beckwith J B, Kiviat N B, Bonadio J F. Nephrogenic rests, nephroblastomatosis, and the pathogenesis of Wilms' tumor. Pediatr Pathol 1990; 10: 1–36
- Beckwith J B. Precursor lesions of Wilms' tumor: Clinical and biological implications. Med Pediatr Oncol 1993; 21: 158–68
- Bove K E, McAdams A J. The nephroblastomatosis complex and its relationship to Wilms' tumor: A clinicopathologic treatise. Perspect Pediatr Pathol 1976; 3: 185–223
- Rachmilewitz J, Goshen R, Ariel I, Schneider T, de Groot N, Hochberg A. Parental imprinting of the human W19 gene. FEBS Lett 1992; 309: 25–8
- Zhang Y, Tycko B. Monoallelic expresion of the human H19 gene. Nature Genet 1992; 1: 40–4
- Pachnis V, Belayew A., Tilghman S M. Locus unlinked to alpha-fetoprotein under the control of the murine raf and Rif genes. Proc Natl Acad Sci USA 1984; 81: 5523–7
- Lustig O, Ariel I, Lev-Lehman E, de Groot N, Hochberg A. Expression of the imprinted gene H19 in the human fetus. Mol Reprod Dev 1994; 38: 239–46
- Biran H, Ariel I, de Groot N, Shani A, Hochberg A. Human imprinted genes as oncodevelopmental markers. Tumor Biol 1994; 15: 123–34
- Ariel I, Lustig O, Schneider T, et al. The imprinted H19 gene as a tumor marker in bladder carcinoma. Urology 1995; 45: 335–8
- Leighton P A, Ingram R S, Eggenschweiler J, Efstratiadis A, Tilghman S M. Disruption of imprinting caused by deletion of the H19 gene region in mice. Nature 1995; 375: 34–9
- Taniguchi T, Sullivan M J, Ogawa O, Reeve A E. Epigenetic changes encompassing the IGF2/H19 locus associated with relaxation of IGF2 imprinting and silencing of H19 in Wilms' tumor. Proc Natl Acad Sci USA 1995; 92: 2159–63
- Steenman M JC, Rainier S, Dobry C J, Grundy P, Horon I L, Feinberg A P. Loss of imprinting of ICF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumor. Nature Genet 1994; 7: 433–9
- Heppe R K, Koyle M A, Beckwith J B. Nephrogenic rests in Wilms tumor patients with Drash syndrome. J Urol 1991; 145: 1225–8
- Perlman M, Levin M, Witteles B. Syndrome of fetal gigantism, renal hamartomas, and nephroblastomatosis with Wilms' tumor. Cancer 1975; 35: 1212–7
- Van Heyningen V, Hastie N D. Wilms' tumour: Reconciling genetics and biology. Trends Genet 1992; 8: 16–21
- Haber D A, Housman D E. Role of the WT1 gene in Wilms' tumour. Cancer Surv 1992; 12: 105–17
- Rauscher F J, III. The WT1 Wilms tumor gene product: A developmentally regulated transcription factor in the kidney that functions as a tumor suppressor. FASEB J 1993; 7: 896–903
- Drummond I A, Madden S L, Rohwer-Nutter P, Bell G I, Sukhatme V P, Rauscher F J, III. Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1. Science 1992; 257: 674–8
- Reeve A E, Eccles M R, Wilkins R J, Bell G I, Millow L J. Expression of insulin-like growth factor-II transcripts in Wilms' tumour. Nature 1985; 317: 258–60
- Armstrong J F, Pritchard-Jones K, Bickmore W A, Hastie N D, Bard J BL. The expression of the Wilms' tumor gene, WT1, in the developing mammalian embryo. Mech Dev 1992; 40: 85–97
- Vogelstein B, Fearon E R, Kern S E, et al. Allelotype of colorectal carcinoma. Science 1989; 244: 207–11
- Dalbagni G, Presti J, Reuter V, Fair W R, Cordon-Cardo C. Genetic alterations in bladder cancer. Lancet 1993; 342: 469–71
- Bardeesy N, Beckwith J B, Pelletier J. Clonal expansion and attenuated apoptosis in Wilms' tumors are associated with p53 gene mutations. Cancer Res 1995; 55: 215–9